Market needs to see concrete evidence of that. Until then, you get 99 cents.
Very little resistance, much easier to control the agenda. So off to the cleaners with the shareholders, leaving only the doctor to play with himself.
Even though predicted. Growth stocks are not supposed to do that.
Why would that be? Are they just selling to wholesalers/distributors and not end users? If so, that won't last long. Just trying to figure this out.
Somebody's wrong. Hopefully, it's not us.
Won't see that 4th qtr. So Q1 2017 fiscal is 1st test. If revenues not there, credibility will take a big hit.
It's amazing that every one of these boards has a guy like you. Try a more positive thought process; you will live longer.
How will they fund their intentions. Not with patents. Sales, partnerships this is what will move the stock. I don't want any more stock sold at $1. That will turn into a death spiral. That is what is holding down the stock.
Their presentations clearly leave no positive impression on anyone. Six months ago I really thought we had something here. Now, I don't.
Still just a story. Sequential quarterly revenues are in decline and their own 4th qtr projection is poor. Growth stock that is not growing, at least, not yet.
At least it explains the recent implosion. Only $3 million involved so hopefully just a bridge to better days. But the stock has been a major disappointment.